EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

ApoE: The Non-Protagonist Actor in Neurological Diseases

Lorenzo Grimaldi, Eleonora Bovi, Rita Formisano iD, Giulia Sancesario

Genes · 30.10.2024 · 15 (11) · 1397

DOI: 10.3390/genes15111397 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 30.10.2024. Verfasst von Lorenzo Grimaldi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Neurochemistry Unit and Biobank, IRCCS Santa Lucia Foundation, Via Ardeatina, 306/354, 00179 Rome, Italy. Hauptthemen laut MEDLINE: Alzheimer Disease, Apolipoproteins E. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Apolipoprotein E (APOE = gene, ApoE = protein) is a glycoprotein involved in the biological process of lipid transportation and metabolism, contributing to lipid homeostasis. APOE has been extensively studied for its correlation with neurodegenerative diseases, in particular Alzheimer’s disease (AD), where the possession of the epsilon 4 (E4) allele is established as a risk factor for developing AD in non-familiar sporadic forms. Recently, evidence suggests a broad involvement of E4 also in other neurological conditions, where it has been shown to be a predictive marker for worse clinical outcomes in Parkinson’s disease (PD), brain trauma, and disturbances of consciousness. The mechanisms underlying these associations are complex and involve amyloid-β (Aβ) peptide accumulation and neuroinflammation, although many others have yet to be identified.

Objectives

The aim of this review is to overview the current knowledge on ApoE as a non-protagonist actor in processes underlying neurodegenerative diseases and its clinical significance in AD, PD, acquired brain trauma, and Disorders of Consciousness (DoC). Ethical implications of genetic testing for APOE variants and information disclosure will also be briefly discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseApolipoproteins EHumansParkinson DiseaseAmyloid beta-PeptidesNeurodegenerative DiseasesApolipoprotein E4AnimalsNervous System DiseasesConsciousness Disorders

Stichwörter der Autor:innen

Alzheimer’s diseaseParkinson’s diseaseapolipoprotein Ebrain injurydementianeurodegenerative diseasesneuroinflammationstroke

Substanzen

Apolipoproteins EApoE protein, humanAmyloid beta-PeptidesApolipoprotein E4

Autor:innen und Institutionen

  • Clinical Neurochemistry Unit and Biobank, IRCCS Santa Lucia Foundation, Via Ardeatina, 306/354, 00179 Rome, Italy.
  • European Center for Brain Research, Via del Fosso del Fiorano, 00143 Rome, Italy.
  • Parkinson's Disease Unit, University Hospital of Rome "Tor Vergata", Viale Oxford 81, 00133 Rome, Italy.
  • Post-Coma Unit and Neurorehabilitation, IRCCS Santa Lucia Foundation, Via Ardeatina, 306/354, 00179 Rome, Italy.

ORCID-Profile: Rita Formisano

Zitieren

APA

Grimaldi, L., Bovi, E., Formisano, R., & Sancesario, G. (2024). ApoE: The Non-Protagonist Actor in Neurological Diseases. Genes, 15(11), 1397. https://doi.org/10.3390/genes15111397

Vancouver

Grimaldi L, Bovi E, Formisano R, Sancesario G. ApoE: The Non-Protagonist Actor in Neurological Diseases. Genes. 2024;15(11):1397. doi:10.3390/genes15111397

BibTeX
@article{Grimaldi2024,
  author = {Grimaldi, Lorenzo and Bovi, Eleonora and Formisano, Rita and Sancesario, Giulia},
  title = {ApoE: The Non-Protagonist Actor in Neurological Diseases},
  journal = {Genes},
  year = {2024},
  volume = {15},
  number = {11},
  pages = {1397},
  doi = {10.3390/genes15111397}
}
Kostenlos starten →